Skip to main content
P

Precordx

Precordx provides a home‑based cardiopulmonary monitoring system that continuously captures respiratory and cardiac signals using its proprietary Resonant Frequency Sensing (RFS) technology. The device streams high‑resolution data to a secure cloud where real‑time analytics detect early signs of heart‑failure decompensation and atrial fibrillation, delivering alerts and trend reports to clinicians via a web dashboard. This enables cardiology practices and health systems to monitor patients remotely and intervene proactively without frequent clinic visits.

Utrecht, NetherlandsFounded 20225300+ followers
Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Heart failure decompensation and atrial fibrillation often progress without noticeable symptoms, leading to delayed diagnosis and higher mortality. Current monitoring relies on intermittent clinic visits and bulky equipment, which limits timely detection and intervention.

Solution

Precordx offers a home‑based cardiopulmonary monitoring system that continuously tracks key physiological signals related to heart failure and atrial fibrillation. The device uses the company’s proprietary Resonant Frequency Sensing (RFS) technology to capture respiratory and cardiac metrics non‑invasively. Data are streamed in real time to a secure cloud platform where validated algorithms identify early signs of decompensation or arrhythmia. Clinicians can access alerts, trend visualizations, and detailed reports through a web dashboard, enabling proactive treatment adjustments without requiring patients to visit a clinic.

Target Audience

Primary customers are cardiology practices, heart failure and electrophysiology clinics, and healthcare systems seeking remote monitoring solutions for patients with heart failure or atrial fibrillation.

Features

  • Wearable, non‑invasive sensor suite that measures respiration, heart rate, and rhythm continuously
  • Proprietary RFS technology delivering high‑resolution cardiopulmonary signals without electrodes
  • Real‑time cloud analytics that detect early heart failure decompensation and AFib episodes
  • Automated alerts and longitudinal trend graphs delivered to clinicians via a secure web portal
  • Seamless integration with existing electronic health record workflows through standard APIs
  • Patient‑friendly design requiring minimal setup and no daily manual measurements
This profile is AI-generated and may contain inaccuracies.